Editorial Expression of Concern: Two novel human anti-ErbB2 immunoagents are active on trastuzumab-resistant tumours
Fields of Study & Subjects
HER2/EGFR in Cancer Research
Monoclonal and Polyclonal Antibodies Research
Rheumatoid Arthritis Research and Therapies
Publication details
- Journal / source
- British Journal of Cancer
- Volume
- 134
- Issue
- 2
- Pages
- 355–355
- Publication date
- 8 January 2026
- Language
- EN